Citadel Advisors LLC 13D/13G Filings for Aardvark Therapeutics, Inc. Common Stock (AARD)

Citadel Advisors LLC 13D and 13G filings for Aardvark Therapeutics, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-24
5:55 pm
Purchase
2025-02-14 13G Aardvark Therapeutics, Inc. Common Stock
AARD
Citadel Advisors LLC 1,192,971
5.600%
1,192,971increase
(New Position)
Filing